Cargando…
SARS-COV-2 AND MRNA VACCINE-ASSOCIATED RECURRENT PERICARDITIS TREATED WITH RILONACEPT
Autores principales: | Shell, John Clark, Narayanan, Mahesh Anantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982945/ http://dx.doi.org/10.1016/S0735-1097(23)03602-1 |
Ejemplares similares
-
FULMINANT RECURRENT PERICARDITIS, POSSIBLY RELATED TO CORONAVIRUS VACCINATION. OR IS IT ?
por: Schwartzenberg, Shmuel, et al.
Publicado: (2022) -
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis
por: Brucato, Antonio, et al.
Publicado: (2023) -
Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022) -
Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis
por: Affas, Ziad R, et al.
Publicado: (2022) -
EFFUSIVE CONSTRICTIVE PERICARDITIS IN THE SETTING OF RECURRENT COVID-19 INFECTION IN A VACCINATED PATIENT
por: Ahmed, Asmaa, et al.
Publicado: (2023)